Blog

25 October, 2018

Cataluña allocates 9.5 million to Peris, its health innovation plan

Source: redaccionmedica.com The government has approved this Tuesday for 9.550.000 euros to attend the 2019 call for grants of the Strategic Plan for Research and Innovation […]
23 October, 2018

New advances in the treatment of head and neck tumors

Source: immedicohospitalario.es Immunotherapy with pembrolizumab improves survival in patients with head and neck cancer that has recurred or metastasized according to the most recent results of […]
19 October, 2018

Gilead increases its commitment to research in Spain targeting HIV

Source: redaccionmedica.com The biopharmaceutical company Gilead Sciences continues its commitment to research in our country, this time, developing a project to achieve the cure of HIV. […]
18 October, 2018

Breast cancer: the industry leads the research of 169 new drugs

Source: redaccionmedica.com Currently, the pharmaceutical industry has a total of 169 new drugs against breast cancer in the clinical research phase, a disease that encompasses the […]
16 October, 2018

Success of the first trial of Opsumit (Actelion) in portopulmonary hypertension

Source: redaccionmedica.com Actelion Pharmaceuticals has announced the results of the first randomized controlled trial in portopulmonary hypertension (HTPP). This study has shown that Opsumit (macitentan) significantly […]
10 October, 2018

Europe approves Verzenios, from Lilly, for the treatment of advanced breast cancer

Source: actasanitaria.com The European Commission has authorized the commercialization of Verzenios (abemaciclib), from the pharmaceutical company Lilly, as a treatment of locally advanced or metastatic breast […]
8 October, 2018

Genetic mutations also alter the nature of clinical trials

Source: immedicohospitalario.es New ways of researching and developing drugs, in their most advanced oncological aspects, urge health administrations, hospitals, patients and their organizations, Research Ethics Committees […]
5 October, 2018

VHIO develops a precision immunotherapy for breast cancer

Source: redaccionmedica.com Researchers at the Vall d’Hebron Institute of Oncology (VHIO) in Barcelona have achieved that immunotherapy attacks only the tumor cells of a type of […]
3 October, 2018

Nobel Prize for Medicine 2018 for cancer immunotherapy

Source: IntraMed The American James Allison and the Japanese Tasuku Honjo have won the Nobel Prize for Medicine 2018. The jury of the Karolinska Institute in […]
26 September, 2018

EMA gives a positive opinion to Gilenya, from Novartis, for minors with multiple sclerosis

Source: actasanitaria.com The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the approval of the drug Gilenya (fingolimod), […]
21 September, 2018

ISCIII will represent Spain in the largest research appointment in Europe

Source: redaccionmedica.com The director of the Health Institute Carlos III (ISCIII), Raquel Yotti Álvarez, in charge of the head of the Spanish delegation at the opening […]
18 September, 2018

Lilly Foundation awards a study of protein kinase in liver disease

Source: Actasanitaria.com Within the framework of the 41st Annual Congress of the Spanish Society of Biochemistry and Molecular Biology (SEBBM), which is being held in Santander, […]
13 September, 2018

AstraZeneca Foundation encourages young talent with 80,000 euros

Source: redaccionmedica.com The AstraZeneca Foundation, in collaboration with the Carlos III Health Institute, has announced the winners of the IV Young Researchers Awards, a recognition that […]
14 March, 2018

Clinical Trials Area of the Hospital Pharmacy Service

Distefar, considera que las funciones que se llevan a cabo en el servicio de farmacia hospitalaria, dentro del entorno de un estudio con medicamentos, son fundamentales […]
20 December, 2022

The pharmaceutical industry reinforces its commitment to Spain and sets a new record in R&D investment, with 1,267 million euros

The figure reached in 2021 is 9% higher than in 2020, when, despite the pandemic, the sector achieved the second best record in its history up […]
13 December, 2022

Revolutionary therapy targets the most serious cancers by ‘doping’ the immune system

A Dutch team has developed a cell therapy for metastatic melanoma that improves on the current standard. Source: elespanol.com Researchers in the Netherlands and Denmark have […]
12 December, 2022

Farmaindustria promotes the creation of a working group to promote clinical trials in primary care

Representatives of scientific societies, public administrations, researchers and pharmaceutical companies make up the group. Clinical research at this level of care has a great opportunity for […]
1 December, 2022

AEMPS Bulletin November 2022 on medicinal products for human use

Source: actasanitaria.com This report outlines the medicines already assessed by the Spanish Agency for Medicines and Health Products (AEMPS), which are considered to be of greatest interest […]
21 November, 2022

New drugs associated with a 29% reduction in cancer deaths in Spain in a single year

A study by Professor Lichtenberg of Columbia University attributes up to 96% of the increase in life expectancy in cancer patients and a high degree of […]
15 November, 2022

Europe is losing weight in R&D investment in new drugs in the face of US and China’s drive

A report by the European Federation of the Pharmaceutical Industry (Efpia) insists that our continent has lost 25% of its weight in this area in the […]
10 November, 2022

“There must be a national commitment for Spain to remain at the forefront of clinical research”.

Increased international competitiveness and digitalisation will require more investment in infrastructure and resources to ensure that our country remains at the forefront of biomedical R&D Source: […]
27 October, 2022

Multiple sclerosis patients interested in clinical trials

Farmaindustria explains to Esclerosis Múltiple Euskadi what these studies consist of, how to take part in them and how research into this pathology is progressing Source: […]
25 October, 2022

The pharmaceutical industry leads the world in R&D investment: it now exceeds 200 billion a year

Aerospace and defence investment is eight times higher than in the aerospace and defence industry, seven times higher than in the chemical industry, and twice as […]
17 October, 2022

Biomedical R&D advances in the aftermath of the pandemic: the pharmaceutical industry has 8,000 drugs under investigation, 10% of them for rare diseases

Oncology, infectious diseases, neurology, haematology and endocrinology are the areas with the highest number of clinical trials with new treatments underway. Seven out of ten molecules […]
27 September, 2022

Argentinean health authorities and pharmaceutical industry are interested in the keys to Spain’s leadership in clinical research

Farmaindustria explains to some twenty experts some of the policies and initiatives that have made Spain an international benchmark in clinical drug trials Source: farmaindustria.es Representatives […]
19 July, 2022

More training and information to move towards excellence in clinical trials in Spain

Farmaindustria organises workshops with representatives of the Spanish Data Protection Agency and the Spanish Medicines Agency to continue working on the implementation of the new Code […]